Central statistical monitoring: Detecting fraud in clinical trials
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background: Central statistical monitoring in multicenter trials could allow trialists to identify centers with problematic data or conduct and intervene while the trial is still ongoing. Currently, there are few published models that can be used for this purpose. Purpose: To develop and validate a series of risk scores to identify fabricated data within a multicenter trial, to be used in central statistical monitoring. Methods: We used a database from a multicenter trial in which data from 9 of 109 centers were documented to be fabricated. These data were used to build a series of risk scores to predict fraud at centers. All analyses were performed at the level of the center. Exploratory factor analysis was used to select from 52 possible predictors, chosen from a variety of previously published methods. The final models were selected from a total of 18 independent predictors, based on the factors identified. These models were converted to risk scores for each center. Results: Five different risk scores were identified, and each had the ability to discriminate well between centers with and without fabricated data (area under the curve values ranged from 0.90 to 0.95). True- and false-positive rates are presented for each risk score to arrive at a recommended cutoff of seven or above (high risk score). We validated these risk scores, using an independent multicenter trial database that contained no data fabrication and found the occurrence of false-positive high scores to be low and comparable to the model-building data set. Limitations: These risk score have been validated only for their false-positive rate and require validation within another trial that contains centers that have fabricated data. Validation in noncardiovascular trials is also required to gage the usefulness of these risk scores in central statistical monitoring. Conclusions: With further validation, these risk scores could become part of a series of tools that provide evidence-based central statistical monitoring, which in turn can improve the efficiency of trials, and minimize the need for more expensive on-site monitoring.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ensuring trial validity by data quality assurance and diversification of monitoring methods
Baigent, C., Harrell, F. E., Buyse, M., Emberson, J. R., & Altman, D. G. (2008) · Clinical Trials · doi:10.1177/1740774507087554 · Cited by 163 · cited 6×
“Traditionally, quality assurance for clinical trials has included trial oversight committees (trial management committee, trial steering committee, and data monitoring committee); central monitoring of center performance, including central statistical monitoring; and on-site monitoring [1].”
BackgroundInfluentialWeiss, R. B. (1993) · JAMA · doi:10.1001/jama.1993.03510040063030 · Cited by 70
Cited by
Good practices for quantitative bias analysis
Lash, T. L., Fox, M. P., MacLehose, R. F., Maldonado, G., McCandless, L. C., & Greenland, S. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyu149 · Cited by 646
Data fraud in clinical trials.
George, S. L., & Buyse, M. (2015) · Clinical Investigation · doi:10.4155/cli.14.116 · Cited by 126
Methods to assess research misconduct in health-related research: A scoping review
Bordewijk, E. M., Li, W., van Eekelen, R., Wang, R., Showell, M., Mol, B. W., & van Wely, M. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2021.05.012 · Cited by 68
van den Bor, R. M., Vaessen, P. W. J., Oosterman, B. J., Zuithoff, N. P. A., Grobbee, D. E., & Roes, K. C. B. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.03.018 · Cited by 22
Knepper, D., Lindblad, A. S., Sharma, G., Gensler, G. R., Manukyan, Z., Matthews, A. G., & Seifu, Y. (2016) · Therapeutic Innovation & Regulatory Science · doi:10.1177/2168479016630576 · Cited by 19
Metadata
- Authors
- Pogue, J. M., Devereaux, P., Thorlund, K., & Yusuf, S.
- Venue
- Clinical Trials
- Publisher
- SAGE Publications
- Published
- 2013-01-02
- Volume
- 10
- Issue
- 2
- Pages
- 225-235
- ISSN
- 1740-7745 (ISSN-L)
- 1740-7753
- OpenAlex
- W2035324238
- Cited by
- 51
- References
- 2
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Central statistical monitoring: Detecting fraud in clinical trials. https://app.cochat.ai/papers/10.1177/1740774512469312
- The paper
- Pogue, J. M., Devereaux, P., Thorlund, K., & Yusuf, S. (2013). Central statistical monitoring: Detecting fraud in clinical trials. Clinical Trials. https://doi.org/10.1177/1740774512469312
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.